Overview

Safety, Tolerability, and Efficacy of AEB071 in the Treatment of Uveitis

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability, and efficacy of AEB071 as a therapy for uveitis. Vision improvement and reduction in the swelling of retina will be measured for the assessment of efficacy.
Phase:
Phase 2
Details
Lead Sponsor:
Novartis